Brancolini C - Search Results

1

Type I IFNs signaling and apoptosis resistance in glioblastoma cells.

Sgorbissa A, Tomasella A, Potu H, Manini I, Brancolini C. Sgorbissa A, et al. Among authors: brancolini c. Apoptosis. 2011 Dec;16(12):1229-44. doi: 10.1007/s10495-011-0639-4. Apoptosis. 2011. PMID: 21858676

2

Proteolytic processing of the adherens junctions components beta-catenin and gamma-catenin/plakoglobin during apoptosis.

Brancolini C, Sgorbissa A, Schneider C. Brancolini C, et al. Cell Death Differ. 1998 Dec;5(12):1042-50. doi: 10.1038/sj.cdd.4400443. Cell Death Differ. 1998. PMID: 9894611

3

Caspase-3 and caspase-7 but not caspase-6 cleave Gas2 in vitro: implications for microfilament reorganization during apoptosis.

Sgorbissa A, Benetti R, Marzinotto S, Schneider C, Brancolini C. Sgorbissa A, et al. Among authors: brancolini c. J Cell Sci. 1999 Dec;112 ( Pt 23):4475-82. doi: 10.1242/jcs.112.23.4475. J Cell Sci. 1999. PMID: 10564664

4

The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis: A COMPARATIVE STUDY WITH THE PROTEASOME INHIBITOR BORTEZOMIB.

Fontanini A, Foti C, Potu H, Crivellato E, Maestro R, Bernardi P, Demarchi F, Brancolini C. Fontanini A, et al. Among authors: brancolini c. J Biol Chem. 2009 Mar 27;284(13):8369-81. doi: 10.1074/jbc.M806113200. Epub 2009 Jan 12. J Biol Chem. 2009. PMID: 19139105 Free PMC article.

5

Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system.

Foti C, Florean C, Pezzutto A, Roncaglia P, Tomasella A, Gustincich S, Brancolini C. Foti C, et al. Among authors: brancolini c. Mol Cancer Ther. 2009 Nov;8(11):3140-50. doi: 10.1158/1535-7163.MCT-09-0431. Epub 2009 Nov 3. Mol Cancer Ther. 2009. PMID: 19887551

6

Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosis.

Potu H, Sgorbissa A, Brancolini C. Potu H, et al. Among authors: brancolini c. Cancer Res. 2010 Jan 15;70(2):655-65. doi: 10.1158/0008-5472.CAN-09-1942. Epub 2010 Jan 12. Cancer Res. 2010. PMID: 20068173

7

Isopeptidases in anticancer therapy: looking for inhibitors.

Sgorbissa A, Potu H, Brancolini C. Sgorbissa A, et al. Among authors: brancolini c. Am J Transl Res. 2010 May 10;2(3):235-47. Am J Transl Res. 2010. PMID: 20589164 Free PMC article.

8

IFNs, ISGylation and cancer: Cui prodest?

Sgorbissa A, Brancolini C. Sgorbissa A, et al. Among authors: brancolini c. Cytokine Growth Factor Rev. 2012 Dec;23(6):307-14. doi: 10.1016/j.cytogfr.2012.07.003. Epub 2012 Aug 18. Cytokine Growth Factor Rev. 2012. PMID: 22906767 Review.

9

MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation.

Di Giorgio E, Clocchiatti A, Piccinin S, Sgorbissa A, Viviani G, Peruzzo P, Romeo S, Rossi S, Dei Tos AP, Maestro R, Brancolini C. Di Giorgio E, et al. Among authors: brancolini c. Mol Cell Biol. 2013 Nov;33(22):4473-91. doi: 10.1128/MCB.01050-13. Epub 2013 Sep 16. Mol Cell Biol. 2013. PMID: 24043307 Free PMC article.

10

The DeISGylase USP18 limits TRAIL-induced apoptosis through the regulation of TRAIL levels: Cellular levels of TRAIL influences responsiveness to TRAIL-induced apoptosis.

Manini I, Sgorbissa A, Potu H, Tomasella A, Brancolini C. Manini I, et al. Among authors: brancolini c. Cancer Biol Ther. 2013 Dec;14(12):1158-66. doi: 10.4161/cbt.26525. Epub 2013 Sep 19. Cancer Biol Ther. 2013. PMID: 24153058 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters